Published online Sep 6, 2023. doi: 10.12998/wjcc.v11.i25.5857
Peer-review started: February 18, 2023
First decision: May 8, 2023
Revised: May 28, 2023
Accepted: August 9, 2023
Article in press: August 9, 2023
Published online: September 6, 2023
Processing time: 194 Days and 15.8 Hours
For patients with atrial fibrillation with an increased risk of stroke and contraindications to long-term anticoagulation, percutaneous left atrial appendage closure (LAAC) has become an important alternative to long-term oral anticoagulation. Incomplete closure of the LAAC during the procedure leads to faster blood flow in the interstitial space around the device, resulting in peri-device leak (PDL), which is not uncommon. Studies are still inconclusive in determining the incidence, long-term safety, and management of PDL. Therefore, this article reviewed the progress made in the research and treatment of PDL after LAAC.
Core Tip: For patients with atrial fibrillation with an increased risk of stroke and contraindications to long-term anticoagulation, percutaneous left atrial appendage closure has become an important alternative to long-term oral anticoagulation. Incomplete closure of the left atrial appendage closure during the procedure leads to faster blood flow in the interstitial space around the device, resulting in peri-device leak. The incidence, long-term safety, and management of peri-device leak are still inconclusive.
